JTC-064

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameJTC-064
Drug Alias NameJTC-064
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPyruvate dehydrogenase kinase inhibitors
TargetsPyruvate dehydrogenase kinase
Therapy Area/IndicationsNerve Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesJt Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesAkros Pharma IncJt Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsNerve Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A